PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-When will a vaccine be ready? Here's a guess!

Wed, 13th May 2020 11:58

* European shares slump on virus fears

* Banks hit by earnings

* EZ industry output suffers record fall in March
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and
Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) in Milan.

WHEN WILL A VACCINE BE READY? HERE'S A GUESS! (1050 GMT)

Assuming that countries in Europe aren't aiming at the so called "herd immunity", which
involves 60 to 90% of the population being infected by coronavirus, a vaccine could be the key
to return to a pre COVID-19 life.

A limited number of vaccine doses could be available before year end, says the European
pharma team at Credit Suisse.

With unlimited potential demand and governments controlling the vaccine distribution, supply
could jump to more than 1 billion doses by mid-2021.

The Swiss bank expects first safety data from human trials in the next few months from
Oxford/Astrazeneca, Sinovac and Novavax.

Once the vaccine is out there, for every 100 million doses CS sees a potential uplift to
2025 EPS of 2.6% for Sanofi, 2.3% for Astrazeneca and 1.1% GlaxoSmithKline.

The pharma team modelled sales/profits based on the current $5-6 billion flu vaccine market
where the average price per dose is $10 and over 200 million doses are produced annually.

(Stefano Rebaudo)

*****

CAUTIOUS AND SELECTIVE STOCKS RECOVERY LOOMING (0845 GMT)

The most likely scenario now is a cautious recovery in stock markets, as fears of a second
wave of infections will weigh at least for a while but huge stimulus programs already under way
will prop up share prices.

The latest rally was all about P/E ratio expansion after the ECB "opened the liquidity tap"
and the "markets internals are not risk-on" yet, Barclays says in a research note.

In this scenario the investment bank suggests "to use dips to add selectively to cyclicals,"
after downgrading Telecoms to underweight, while it is overweight on Tech, Mining, Cap Goods,
Healthcare and Utilities in defensives.

Barring the feared second wave of the virus, the economy will show signs of recovery and we
should not forget that "buying equities when PMIs bottom has been a typically better strategy
than buying when they are peaking."

If PMIs rebound and "history repeats itself, cyclicals should outperform".

(Stefano Rebaudo)

*****

OPENING SNAPSHOT: RISK-OFF MOOD HITS BANKS, VODAFONE UP (0737 GMT)

Risk-off mood gripped the financial markets on fresh fears about a second wave of the
coronavirus outbreak, while the gradual easing in lockdowns is under way.

Banks, and automotive sectors are the worst hit, down almost 3%. While utilities, retail and
telcos are standing their ground even if in negative territory.

ABN Amro is among the top losers in the Stoxx 600 index, down 7.1%, after a 395 million euro
loss, hit by loan provisions of 1.1 billion euros. Commerzbank shares down more than 3% after
posting a loss in Q1.

Arcelormittal under further pressure, after some target price cuts by investment banks. The
company recently announced an issue of shares and convertible notes worth $2 billion.

Agnelli's family holding company Exor is down 4.7% after French insurer Covea walked away
from its planned $9 billion purchase of the Bermuda-based reinsurer PartnerRe.

Vodafone shares in positive territory, as the company posted on Tuesday results in
line with expectations and said it would maintain its dividend.

(Stefano Rebaudo)

*****

NEGATIVE RATES, THE ULTIMATE FED 'PUT'? (0713 GMT)

There's nothing like the smell of negative interest in the morning to spice things up!

Powell's speech this afternoon (1300 GMT) will definitely be a key moment for the session
after Trump pressured the Fed to look into "the gift" of negative rates.

"I am looking at that bounce back in US e-minis, and once again, investors are counting on
Fed Chair Powell to grease the wheels off yet another equity markets recovery rally", writes
AxiCorp strategist Stephen Innes, pointing out to positive Wall Street futures currently
outperforming European bourses in the red.

"All that policy deluge before even thinking about negative rates, which is arguably their
ace in the hole for more rainy days, has got investors lining up for their rally bus tickets
again", he commented.

This could of course very well also end up in a case of 'buy the rumour, sell the news' if
Powell brushes off the idea of going subzero.

"The central banker might use the opportunity to nip the negative rates chatter in the bud",
warned at CMC Markets analyst David Madden.

Anyhow, we still got a few hours to wait so let's take a look at the last 20 years of the 10
year U.S. benchmark and see if we can see a trend about where it's heading:

(Julien Ponthus)

*****

ON THE RADAR: L'OREAL, BANKS, ASTON MARTIN AND VOLVO (0635 GMT)

European bourses are coming under renewed selling pressure as fears of a new wave of
infections are gripping financial markets.

On the corporate front, L'Oreal decided to give up on share buyback programmes in
2020 and on a planned 10.4% dividend increase, but to stick to the same 2019 payout per share of
3.80 euros.

More banks are swinging to the red in the first quarter. Commerzbank posted a worse than
expected net loss of 295 million euros, as the lender undergoes a restructuring due to the
coronavirus outbreak. Commerzbank shares are down 2.3% in early trade.

Ducth bank ABN Amro reported a 395 million euro loss, hit by loan provisions of 1.1 billion
euros. Meantime, Deutsche Bank top managers will waive one month of fixed pay, in an effort to
cut costs; shares are down 2% in early trade.

The travel and leisure industry stays on the radar as TUI said it needed to cut
its fixed cost base by 30% and thousands of jobs as it looks to right-size its business to
survive.

Car makers Aston Martin posted a first-quarter pretax loss of 119 million pound,
after sales dropped by nearly a third, while Volvo ditched dividend payment.

Moller-Maersk first-quarter revenue were in line with expectations, but the company warned
about a drop of as much as 25% in global container volumes in the second quarter.

Alstom is sticking to the terms of its previously agreed deal to buy the rail
division of Canada's Bombardier for up to 6.2 billion euros.

But another acquisition falls through with Exor saying it will retain control of
Bermuda-based reinsurer ParnerRe after Covea walked away from the $9 billion deal acquisition.

Eiffage first-quarter construction revenue slumped 13.0%.

Salvatore Ferragamo, whose core profits plunged by 82.2% to 12 million euros in the three
months to March said it could not provide guidance on expected sales for 2020.

(Stefano Rebaudo)

*****

MORNING CALL: IN THE RED ON RENEWED CORONAVIRUS FEARS (0636)

European futures are in the red amid fears of a fresh spike in coronavirus cases and renewed
U.S.-China tensions.

Wall Street's fall overnight seems set to hit a fragile European market, which has recently
swung between optimism over some easing in lockdowns and anxiety about a second wave of
infections.

U.S. markets sentiment soured after U.S. infectious disease expert Anthony Fauci warned that
a premature lifting of social distancing measures could lead to additional outbreaks.

Fresh trade war fears also emerged when a leading U.S. Republican senator proposed
legislation that would authorize Trump to impose sanctions on China if it fails to give a full
account of events leading to the outbreak.

(Stefano Rebaudo)

*****

(Reporting by Joice Alves, Julien Ponthus and Stefano Rebaudo)

More News
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.